Is there cross-reactivity between cefaclor and cefazolin (Ancef)?

Cross-Reactivity Between Cefaclor and Cefazolin (Ancef)

There is minimal to no clinically significant cross-reactivity between cefaclor and cefazolin (Ancef) because they have different R1 side chains, which are the primary determinants of allergic cross-reactivity between cephalosporins. If a patient has an allergy to one of these drugs, the other can generally be safely administered, though the clinical context and type of reaction matter.

Understanding the Mechanism

Cross-reactivity between cephalosporins is primarily driven by identical or similar R1 side chains, not by the shared beta-lactam ring 1. According to the 2022 Drug Allergy Practice Parameter:

• Cefaclor and cefazolin do NOT share R1 side chains 1
• Cefazolin has a unique side chain structure that distinguishes it from most other cephalosporins 1
• The outdated "10% cross-reactivity" warning on package inserts 2, 3 was based on pre-1980 data when cephalosporins were contaminated with penicillins and is not clinically accurate

Clinical Evidence

Cefazolin demonstrates remarkably low cross-reactivity:

• Only 0.8% reaction rate in patients with confirmed penicillin allergy 1
• Appears to be a selective hypersensitivity in most cases 4, 5
• Multiple studies show patients allergic to cefazolin tolerate other cephalosporins with different R1 side chains 4, 6

Cefaclor belongs to the aminocephalosporin group (shares R1 side chains with cephalexin, cefadroxil, cefprozil) 1, which has higher cross-reactivity with aminopenicillins (amoxicillin/ampicillin) at approximately 16-20% 1, 7, but NOT with cefazolin.

Practical Recommendations

If Patient Has Cefaclor Allergy:

• Cefazolin can be safely administered without special precautions in most cases
• The different R1 side chains make cross-reactivity highly unlikely
• Consider skin testing only if the cefaclor reaction was anaphylaxis and you're using parenteral cefazolin 1

If Patient Has Cefazolin Allergy:

• Cefaclor can be safely administered
• Studies show cefazolin-allergic patients tolerate other cephalosporins with different R1 side chains 4, 6
• A graded challenge may be appropriate for oral cefaclor if the cefazolin reaction was severe 1

Important Caveats

Do NOT use either drug if:

• History of severe cutaneous adverse reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis, DRESS) to any beta-lactam 1
• Organ-specific reactions (hemolytic anemia, drug-induced liver injury, acute interstitial nephritis) 1
• Serum sickness to any cephalosporin 1

For anaphylactic reactions:

• If the patient had anaphylaxis to cefaclor and needs parenteral cefazolin, perform skin testing first 1
• If negative skin test, proceed with a 1-2 step drug challenge 1
• If the patient had anaphylaxis to cefazolin and needs oral cefaclor, a graded challenge after negative skin testing is reasonable 1

The Bottom Line

The FDA labels for both drugs 2, 3 contain outdated warnings about "up to 10%" cross-reactivity that do not reflect current evidence. Modern data clearly demonstrates that cefaclor and cefazolin have distinct allergenic profiles due to different R1 side chains, making cross-reactivity between them negligible 1. Using alternative antibiotics unnecessarily increases morbidity, mortality, and healthcare costs 1.